Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q2 2025 Earnings Conference August 13, 2025 4:30 PM ET
Company Participants
Anthony J. Bergmann – CFO & Corporate Treasurer
Linda Marbán – Co-Founder, President, CEO & Director
Conference Call Participants
Aydin Huseynov – Ladenburg Thalmann & Co. Inc., Research Division
Catherine Clare Novack – JonesTrading Institutional Services, LLC, Research Division
Edward Andrew Tenthoff – Piper Sandler & Co., Research Division
Joseph Pantginis – H.C. Wainwright & Co, LLC, Research Division
Kristen Brianne Kluska – Cantor Fitzgerald & Co., Research Division
Leland James Gershell – Oppenheimer & Co. Inc., Research Division
Madison Britt Wynne El-Saadi – B. Riley Securities, Inc., Research Division
Matthew J Venezia – Alliance Global Partners, Research Division
Operator
Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics Second Quarter 2025 Conference Call. [Operator Instructions] This call is being recorded on Monday, August 11, 2025. I would now like to turn the conference over to CFO, A.J. Bergmann, for the forward-looking statements. Please go ahead.
Anthony J. Bergmann
Thank you, and good afternoon, everyone. Before we start, I would like to state that we will be making certain forward-looking statements during today’s presentation. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our product candidates, our future research and development plans, including our anticipated conduct and timing of preclinical and clinical studies, our enrollment of patients in our clinical studies, our plans to present or report additional data, our plans regarding regulatory filings, potential regulatory developments involving our product candidates, potential regulatory inspections, revenue and reimbursement estimates, projected terms of definitive agreements, manufacturing capabilities, potential milestone payments and our financial position and possible uses of existing cash and investment resources.
Forward-looking statements are based on current information, assumptions and expectations that are subject to change
#Capricor #Therapeutics #CAPR #Earnings #Conference #Call #Transcript